Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil E Kay

Showing results (71-80 of 325) with videos related to

Pageof 33
Sort By:
Diagnostic Pathology|April 22, 2008
Dysregulated angiogenesis in B-chronic lymphocytic leukemia: morphologic, immunohistochemical, and flow cytometric evidenceJohn L Frater, Neil E Kay, Charles L Goolsby, et al.
Leukemia & Lymphoma|May 19, 2016
Tris (dibenzylideneacetone) dipalladium: a small-molecule palladium complex is effective in inducing apoptosis in chronic lymphocytic leukemia B-cellsNeil E Kay, Traci Sassoon, Charla Secreto, et al.
Blood|March 5, 2004
VEGF receptor phosphorylation status and apoptosis is modulated by a green tea component, epigallocatechin-3-gallate (EGCG), in B-cell chronic lymphocytic leukemiaYean K Lee, Nancy D Bone, Ann K Strege, et al.
Cancer|March 28, 2006
Complete response in multiple myeloma: clinical trial E9486, an Eastern Cooperative Oncology Group study not involving stem cell transplantationRobert A Kyle, Traci Leong, Shuli Li, et al.
Leukemia|April 30, 2026
Measurable residual disease is not a universally reliable surrogate for progression-free survival in clinical trials of new chronic lymphocytic leukemia therapiesYun Wang, Chunhua Li, Robert Peter Gale, et al.
Mayo Clinic Proceedings|March 11, 2004
Expression of the chemokine receptors CXCR4 and CCR7 and disease progression in B-cell chronic lymphocytic leukemia/ small lymphocytic lymphomaIrene M Ghobrial, Nancy D Bone, Mary J Stenson, et al.
Molecular Cancer Research : MCR|March 26, 2003
Identification of a global gene expression signature of B-chronic lymphocytic leukemiaDiane F Jelinek, Renee C Tschumper, Gustavo A Stolovitzky, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 10, 2008
Karyotype evolution on fluorescent in situ hybridization analysis is associated with short survival in patients with chronic lymphocytic leukemia and is related to CD49d expressionTait D Shanafelt, Curtis Hanson, Gordon W Dewald, et al.
Leukemia & Lymphoma|March 5, 2014
The impact of race, ethnicity, age and sex on clinical outcome in chronic lymphocytic leukemia: a comprehensive Surveillance, Epidemiology, and End Results analysis in the modern eraChadi Nabhan, Briseis Aschebrook-Kilfoy, Brian C-H Chiu, et al.
Leukemia & Lymphoma|March 13, 2023
Functional humoral and cellular response of monovalent COVID-19-vaccines against Omicron BA.2 variant of SARS-CoV-2 in patients with chronic lymphocytic leukemiaMatteo Passerini, Tamar Ratishvili, Jonathon M Monroe, et al.
Pageof 33

Showing results (71-80 of 325) with videos related to

Sort By:
Pageof 33
Diagnostic Pathology|April 22, 2008
Dysregulated angiogenesis in B-chronic lymphocytic leukemia: morphologic, immunohistochemical, and flow cytometric evidenceJohn L Frater, Neil E Kay, Charles L Goolsby, et al.
Leukemia & Lymphoma|May 19, 2016
Tris (dibenzylideneacetone) dipalladium: a small-molecule palladium complex is effective in inducing apoptosis in chronic lymphocytic leukemia B-cellsNeil E Kay, Traci Sassoon, Charla Secreto, et al.
Blood|March 5, 2004
VEGF receptor phosphorylation status and apoptosis is modulated by a green tea component, epigallocatechin-3-gallate (EGCG), in B-cell chronic lymphocytic leukemiaYean K Lee, Nancy D Bone, Ann K Strege, et al.
Cancer|March 28, 2006
Complete response in multiple myeloma: clinical trial E9486, an Eastern Cooperative Oncology Group study not involving stem cell transplantationRobert A Kyle, Traci Leong, Shuli Li, et al.
Leukemia|April 30, 2026
Measurable residual disease is not a universally reliable surrogate for progression-free survival in clinical trials of new chronic lymphocytic leukemia therapiesYun Wang, Chunhua Li, Robert Peter Gale, et al.
Mayo Clinic Proceedings|March 11, 2004
Expression of the chemokine receptors CXCR4 and CCR7 and disease progression in B-cell chronic lymphocytic leukemia/ small lymphocytic lymphomaIrene M Ghobrial, Nancy D Bone, Mary J Stenson, et al.
Molecular Cancer Research : MCR|March 26, 2003
Identification of a global gene expression signature of B-chronic lymphocytic leukemiaDiane F Jelinek, Renee C Tschumper, Gustavo A Stolovitzky, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 10, 2008
Karyotype evolution on fluorescent in situ hybridization analysis is associated with short survival in patients with chronic lymphocytic leukemia and is related to CD49d expressionTait D Shanafelt, Curtis Hanson, Gordon W Dewald, et al.
Leukemia & Lymphoma|March 5, 2014
The impact of race, ethnicity, age and sex on clinical outcome in chronic lymphocytic leukemia: a comprehensive Surveillance, Epidemiology, and End Results analysis in the modern eraChadi Nabhan, Briseis Aschebrook-Kilfoy, Brian C-H Chiu, et al.
Leukemia & Lymphoma|March 13, 2023
Functional humoral and cellular response of monovalent COVID-19-vaccines against Omicron BA.2 variant of SARS-CoV-2 in patients with chronic lymphocytic leukemiaMatteo Passerini, Tamar Ratishvili, Jonathon M Monroe, et al.
Pageof 33